Document is current
Any future updates will be listed below
-
Authors
Inomata, Takenori
Sung, Jaemyoung
Nagino, Ken
Midorikawa-Inomata, Akie
Eguchi, Atsuko
Adachi, Takeya
Kobayashi, Hiroyuki
Nakao, Shintaro
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (24ek0410090s0503)
Japan Society for the Promotion of Science (23K16364, 22K16983)
- License Information
-
More Information
Article History
Received: 24 October 2024
Accepted: 4 March 2025
First Online: 10 March 2025
Declarations
:
: AllerSearch was created using Apple’s ResearchKit (Cupertino, CA, USA). T.I. is the owner of InnoJin, Inc., Tokyo, Japan who developed AllerSearch. T.I. reports non-financial support from Lion Corporation. and Sony Network Communications Inc.; grants from Yuimedi Inc., ROHTO Pharmaceutical Co. Ltd., Kobayashi Pharmaceutical Co. Ltd., and Kandenko Co. Ltd.; and personal fees from Santen Pharmaceutical Co. Ltd., and InnoJin Inc., outside the submitted work. K.N. and A.M.I. reported receiving personal fees from InnoJin, Inc. S.N. reported grants from Kowa Co. Ltd., Mitsubishi Tanabe Pharma Corp., Alcon Japan, Ltd., Santen Pharmaceutical Co. Ltd., Machida Endoscope Co. Ltd., Wakamoto Pharmaceutical Co. Ltd., Bayer Yakuhin Ltd., Senju Pharmaceutical Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Chugai Pharmaceutical Co. Ltd., Hoya Corp., and Novartis Pharma KK, outside the submitted work. The remaining authors declare no competing interests.
